Texas Instruments (TXN US)
TXN US$309.81
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 309.81
- Change
- ▲ 0.90 (0.29)
- Bid / Ask
- 305.00 - 314.23
- Volume
- 3,264,125
- Turnover
- 187,792,267
- Open
- 308.79
- Day Range
- 304.99 - 310.00
- VWAP
- 307.91
- Prev Close
- 308.91
- Last Trade
- 28/10 4:00pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Technology
- Shares Issued
- 913,247,686
- NTA/Share
- 12.91
- Last Dividend
- 1.42
- Dividend Ex Date
- 31 JUL 2026
- Dividend Pay Date
- 11 AUG 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 17,682.00
- EBITDA
- 8,252.00
- Profit
- 4,973.00
- Earnings Per Share (EPS)
- 5.45
- Dividend Per Share (DPS)
- 5.50
- Yield %
- 1.83
- Market Cap
- 282,933.27
- Price to Earnings Ratio (P/E)
- 47.08
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 26,270.79
- EBITDA
- 15,240.29
- Profit
- 10,595.01
- Earnings Per Share (EPS)
- 11.38
- Dividend Per Share (DPS)
- 5.98
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Fairly valued
- Economic Moat
- Wide
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 271.83 Fair value 313.52 One-star price 361.60
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 313.52
- Price / Fair Value
- 0.99
- Valuation
- Fairly valued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (271.83) to the one-star price (361.60).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 309.81 |
| Price - 12 month high | 334.00 |
| Price - 12 month low | 152.76 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 8.38 |
| Market capitalization | 283,261.36 |
| 12 Month High price date | 22 JUN 2026 |
| 12 Month Low price date | 20 NOV 2025 |
| Volume - avg. trading volume for the last 3 months | 6.39 |
| Price - 1 Day % Change | 0.29% |
| Price - 13 week price percent change | 11.82% |
| Price - 26 week price percent change | 16.91% |
| Price - 5 Day % Change | 8.84% |
| Price - 52 week price percent change | 85.62% |
| Price - YTD price percent change | 76.61% |
| Price % Change Month To Date | 11.32% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 5.450 |
| EPS excluding extraordinary items - trailing 12 month | 7.710 |
| EPS Normalized - most recent fiscal year | 5.971 |
| Revenue/share - most recent fiscal year | 19.367 |
| Revenue/share - trailing 12 month | 22.670 |
| Book value per share - most recent fiscal year | 17.942 |
| Book value per share - most recent quarter | 20.984 |
| Book value (tangible) per share - most recent fiscal year | 12.905 |
| Book value (tangible) per share - most recent quarter | 15.919 |
| Cash per share - most recent fiscal year | 3.556 |
| Cash per share - most recent quarter | 4.606 |
| Cash Flow per share - most recent fiscal year | 8.131 |
| Cash Flow per share - trailing 12 month | 10.715 |
| Dividend per share - most recent fiscal year | 5.500 |
| Dividends per share - trailing 12 month | 5.680 |
| EBITD per share - trailing 12 month | 11.961 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 5.470 |
| EPS Basic excluding extraordinary items - trailing 12 month | 7.760 |
| EPS including extraordinary items - most recent fiscal year | 5.470 |
| EPS including extraordinary items - trailing 12 month | 7.760 |
| Free Cash Flow per share - trailing 12 month | 7.901 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 40.19 |
| P/E Normalized, most recent fiscal year | 37.94 |
| Price to sales - most recent fiscal year | 13.67 |
| Price to Tangible Book - most fiscal year | 19.46 |
| Price to Free Cash Flow per Share - most recent fiscal year | 39.22 |
| Price to Cash Flow per share - trailing 12 month | 28.92 |
| Price to Book - most recent fiscal year | 14.76 |
| P/E excluding extraordinary items high, trailing 12 months | 56.90 |
| P/E excluding extraordinary items low, trailing 12 months | 27.93 |
| Net Debt, LFI | 5,413.00 |
| Net Debt, LFY | 9,167.00 |
| Dividend Yield - 5 Year Average | 2.65% |
| Dividend Yield - indicated annual dividend divided by closing price | 1.84% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 1.83% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 2,874.00 |
| LT debt/equity - most recent fiscal year | 83.25% |
| Payout ratio - most recent fiscal year | 100.92% |
| Total debt/total equity - most recent fiscal year | 86.33% |
| LT debt/equity - most recent quarter | 67.27% |
| Total debt/total equity - most recent quarter | 70.65% |
| Free Cash Flow - trailing 12 month | 7,237.00 |
| Payout ratio - trailing 12 month | 38.13% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 17,682.00 |
| Revenue - trailing 12 month | 20,766.00 |
| EBITD - most recent fiscal year | 8,252.00 |
| EBITD - trailing 12 month | 10,956.00 |
| Earnings before taxes - most recent fiscal year | 5,710.00 |
| Earnings before taxes - trailing 12 month | 8,129.00 |
| Net Income available to common - most recent fiscal year | 4,973.00 |
| Net Income available to common - trailing 12 months | 7,072.00 |
| Earnings before taxes Normalized - most recent fiscal year | 6,248.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 8.17 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 28.28% |
| Net Profit Margin % - trailing 12 month | 34.25% |
| Operating margin - 1st historical fiscal year | 34.72% |
| Operating margin - trailing 12 month | 41.12% |
| Pretax margin - trailing 12 month | 39.15% |
| Pretax margin - 1st historical fiscal year | 32.29% |
| Operating Margin - 5 year average | 42.51% |
| Pretax Margin - 5 year average | 41.64% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 21.19% |
| Free Operating Cash Flow/Revenue, TTM | 34.85% |
| Net Profit Margin - 5 year average | 36.43% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 14.39% |
| Return on average assets - trailing 12 month | 20.13% |
| Return on average equity - most recent fiscal year | 30.27% |
| Return on average equity - trailing 12 month | 40.94% |
| Return on average assets - 5 year average | 22.85% |
| Return on average equity - 5 year average | 44.02% |
| Net Income/employee - most recent fiscal year | 151,545.45 |
| Revenue/employee - most recent fiscal year | 535,818.18 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 4.10% |
| EPS growth rate, 5 year | -1.81% |
| Growth rate% - dividend, 3 year | 5.45% |
| Revenue/share (5 yr growth) | 4.56% |
| Growth rate% - Revenue, 3 year | -4.07% |
| Growth rate% - EPS, 3 year | -16.64% |
| Book value per share growth rate, 5 year | 12.42% |
| Capital Spending growth rate, 5 year | 47.62% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 2.77% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
